Sign in to follow
Search Results

0 results for 'Boehringer Ingelheim'

You can use to get even better search results
July 12, 2024 | Connecticut Law Tribune

Boehringer Ingelheim Pharmaceuticals Loses Challenge to Inflation Reduction Act

"We are disappointed by this ruling and what it means for biopharmaceutical innovation," the company said. "Boehringer Ingelheim shares the goal of ensuring our medicines are affordable and available to people who need them. However, we remain concerned about the detrimental and limiting effects the IRA and its 'negotiation' program will have on the future of innovation for the patients we serve."
3 minute read
June 19, 2024 | Law.com

Critical Mass With Law.com's Amanda Bronstad: Boeing CEO Gets Grilled Over Safety Lapses, Talc Plaintiffs File Medical Monitoring Class Action

This week: Many of the victims of Boeing's Max 8 crashes, represented by Clifford Law Offices, attending Tuesday's hearing in Congress. The same plaintiffs' firms that sued last month to stop Johnson & Johnson's planned third bankruptcy filed a new class action Monday seeking medical monitoring on behalf of talc victims. Find out who stepped in for Poppi Prebiotic Sodas in a class action alleging misrepresentations about gut health.
8 minute read
June 14, 2024 | Law.com

After Federal Judge's Dismissal, Zantac Legal Fight Reignites in State Courts

On May 23, the first verdict in the nation over Zantac came out in Illinois, while a Delaware judge's May 31 decision allowed plaintiffs' experts for thousands of cases.
7 minute read
June 12, 2024 | Delaware Business Court Insider

Zantac Defendants: Delaware Could See Mass Tort Surge If Expert Testimony Decision Holds

"The resulting influx of cases could have significant consequences for the efficient administration of justice in Delaware, for both Delaware-domiciled companies and Delaware residents," the defendants said in the application for interlocutory review.
4 minute read
June 12, 2024 | Law.com

Zantac Defendants: Delaware Could See Mass Tort Surge If Expert Testimony Decision Holds

"The resulting influx of cases could have significant consequences for the efficient administration of justice in Delaware, for both Delaware-domiciled companies and Delaware residents," the defendants said in the application for interlocutory review.
4 minute read
Law Journal Press | Digital Book New Jersey Employment Law 2024 Authors: Rosemary Alito View this Book

View more book results for the query "Boehringer Ingelheim"

May 31, 2024 | Litigation Daily

Litigators of the Week: A Defense Verdict in Cook County in the First Zantac Trial

Defense lawyers for GSK, led by Tarek Ismail of Goldman Ismail, and Boehringer Ingelheim, led by Andrew Bayman of King & Spalding, won a defense verdict from state court jurors who rejected a claim that the discontinued heartburn drug Zantac caused an Illinois woman's colon cancer.
7 minute read
May 29, 2024 | Law.com

Critical Mass With Law.com's Amanda Bronstad: Class Action Alleges J&J's 'Fraudulent Maneuvers' Compromised Talc Plaintiffs, MDL Panel to Hear GM Privacy Lawsuits

This week: Plaintiffs' firms opposing Johnson & Johnson's latest bankruptcy plan filed a class action over alleged "fraudulent maneuvers." The U.S. Judicial Panel on Multidistrict Litigation hears big cases on May 30, including suits alleging GM sends driver data to insurance firms. Find out who filed the first class action in the wake of the DOJ's antitrust case against Live Nation and Ticketmaster.
7 minute read
May 23, 2024 | The Recorder

Drug Manufacturers Win First Zantac Verdict in the Nation

An Illinois jury sided with pharmaceutical manufacturers GlaxoSmithKline and Boehringer Ingelheim in the first verdict in the Zantac litigation.
3 minute read
May 23, 2024 | National Law Journal

Drug Manufacturers Win First Zantac Verdict in the Nation

An Illinois jury sided with pharmaceutical manufacturers GlaxoSmithKline and Boehringer Ingelheim.
3 minute read
May 23, 2024 | Law.com

Drug Manufacturers Win First Zantac Verdict in the Nation

An Illinois jury sided with pharmaceutical manufacturers GlaxoSmithKline and Boehringer Ingelheim in the first verdict in the Zantac litigation.
3 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • 2024 Report: State of AI in Legal

    Brought to you by Ironclad

    Download Now

  • Blueprint for Successful Second Request Document Review

    Brought to you by Integreon

    Download Now

  • Employee Happiness Playbook: The 3 R's for Business Success in 2024

    Brought to you by Amazing Workplace, Inc.

    Download Now

  • The Positive Impact of AI at Small Law Firms: 4 Key Insights

    Brought to you by LexisNexis®

    Download Now